Literature DB >> 11267434

Heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy: molecular and biochemical defects on cardiac and skeletal muscle.

P Melacini1, A Gambino, A Caforio, A Barchitta, M L Valente, A Angelini, M Fanin, G Thiene, C Angelini, D Casarotto, G A Danieli, S Dalla-Volta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267434     DOI： 10.1016/s0041-1345(00)02607-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.

Authors:  Saurabh Dahiya; Srikanth Givvimani; Shephali Bhatnagar; Natia Qipshidze; Suresh C Tyagi; Ashok Kumar
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

Review 2.  Treatment of dystrophin cardiomyopathies.

Authors:  Josef Finsterer; Linda Cripe
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 3.  Heart transplantation in patients with dystrophinopathic cardiomyopathy: Review of the literature and personal series.

Authors:  Andrea Antonio Papa; Paola D'Ambrosio; Roberta Petillo; Alberto Palladino; Luisa Politano
Journal:  Intractable Rare Dis Res       Date:  2017-05

Review 4.  Management of pregnancy in the post-cardiac transplant patient.

Authors:  Marwah Abdalla; Donna M Mancini
Journal:  Semin Perinatol       Date:  2014-06-25       Impact factor: 3.300

Review 5.  Cardiac involvement in Becker muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

6.  Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart.

Authors:  Yongping Yue; Zhenbo Li; Scott Q Harper; Robin L Davisson; Jeffrey S Chamberlain; Dongsheng Duan
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

Review 7.  Current and emerging therapies in Becker muscular dystrophy (BMD).

Authors:  Corrado Angelini; Roberta Marozzo; Valentina Pegoraro
Journal:  Acta Myol       Date:  2019-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.